SCHEMBL9687443

SCHEMBL9687443

CCOC(=O)Nc1cccc(C)c1CCl

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.60
HPGD P15428 1/20 0.56
NLRP3 Q96P20 4/20 0.56
SMN1; SMN2 Q16637 1/20 0.53
CYP1A2 P05177 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
GPR35 Q9HC97 1/20 0.50
NPC1 O15118 1/20 0.49
RAB9A P51151 1/20 0.49
GAA P10253 2/20 0.47
MAPK13 O15264 1/20 0.46
MAPK12 P53778 1/20 0.46
MAPK11 Q15759 1/20 0.46
MAPK14 Q16539 1/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
LMNA P02545 1/20 0.44
MAPT P10636 1/20 0.44
MAPK1 P28482 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5901959 0.89 ALDH1A1 (0.47) ALDH1A1HPGDNLRP3GPR35NPC1
SCHEMBL28455248 0.87 ALDH1A1 (0.71) ALDH1A1HPGDNLRP3SMN1; SMN2CYP1A2
SCHEMBL9686499 0.86 ALDH1A1 (0.57) ALDH1A1HPGDNLRP3SMN1; SMN2CYP1A2
SCHEMBL8574405 0.86 NLRP3 (0.45) ALDH1A1HPGDNLRP3SMN1; SMN2CYP1A2
SCHEMBL9687037 0.85 NPC1 (0.72) ALDH1A1NLRP3SMN1; SMN2NPC1RAB9A
SCHEMBL6384294 0.82 LCK (0.43) ALDH1A1NLRP3GPR35NPC1RAB9A
SCHEMBL9687657 0.82 HPGD (0.47) ALDH1A1HPGDNLRP3SMN1; SMN2CYP1A2
SCHEMBL8192482 0.82 RAB9A (0.44) ALDH1A1HPGDGPR35NPC1RAB9A
SCHEMBL9686578 0.81 HPGD (0.45) ALDH1A1HPGDNLRP3SMN1; SMN2GPR35
SCHEMBL9687629 0.81 ALDH1A1 (0.59) ALDH1A1HPGDSMN1; SMN2CYP2C19NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0268989-B1 IMIDAZOPYRIDINE COMPOUNDS AND PROCESSES FOR PREPARATION THEREOF FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-07-08 EP disclosed
US-4920129-A Anti-ulcerative imidazopyridine compounds FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) 1990-04-24 US disclosed
US-4831041-A ANTIULCER AGENTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-05-16 US disclosed
EP-0308917-A2 Imidazopyridine compound, a process for preparation thereof and pharmaceutical compositions comprising them FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-03-29 EP disclosed
EP-0268989-A1 Imidazopyridine compounds and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-06-01 EP disclosed